Study Shows MR-guided FUS Enhances Chemotherapy Delivery to Prostate Tumors


While others explore the ablative potential of MR-guided focused ultrasound to treat early-stage prostate cancer, Lili Chen, Ph.D., has been assessing the technology’s ability to enhance chemotherapy delivery to more advanced prostate tumors. Her recent study, which was supported by a Research Award from the FUS Foundation, was published in the November 2010 issue of Physics in Medicine and Biology. Click here to read full report.